Constance, Germany

Margit Schnee

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 4.3

ph-index = 10

Forward Citations = 376(Granted Patents)


Location History:

  • Konstanz, DE (2018)
  • Constance, DE (2017 - 2024)
  • Tübingen, DE (2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: **Margit Schnee: Innovator in mRNA Vaccine Technology**

Introduction

Margit Schnee is a prominent inventor based in Constance, Germany, with a noteworthy portfolio comprising 19 patents. His innovative contributions primarily focus on developing mRNA sequences for use in vaccines, particularly targeting respiratory infections.

Latest Patents

Schnee’s latest inventions include significant advancements in the development of a respiratory syncytial virus (RSV) vaccine. His patent details an mRNA sequence that encodes at least one antigenic peptide or protein related to RSV infections. The invention encompasses a composition comprising multiple mRNA sequences, which can be utilized in the preparation of pharmaceutical compositions, especially vaccines aimed at the prophylaxis or treatment of RSV infections. Additionally, it outlines methods for using the mRNA sequence in treating or preventing RSV infections, showcasing a pioneering approach in the field of vaccine development.

Career Highlights

Throughout his career, Margit Schnee has held pivotal roles in companies such as CureVac AG and CureVac SE. His work has been instrumental in pushing the boundaries of vaccine technology and addressing critical health challenges through innovative mRNA solutions.

Collaborations

In his journey as an inventor, Schnee has collaborated with notable peers, including Thomas Kramps and Benjamin Petsch. These collaborations have likely enriched his research and innovation processes, fostering an environment of shared knowledge and expertise in the biotechnology sector.

Conclusion

Margit Schnee's contributions to the field of mRNA vaccines position him as a leading figure in innovative healthcare solutions. His dedicated work continues to pave the way for advancements that hold the potential to save lives, particularly in combating infectious diseases like RSV. With a strong foundation in research and collaboration, Schnee exemplifies the impact of innovation within the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…